Evidence of interallelic complementation at clinically relevant loci is limited to biochemical and cell - based studies of a handful of metabolic disorders with defects in enzymes including propinyl - CoA carboxylase [2], argininosuccinate lyase [3], galactose -1-phosphate uridylyltransferase [4], and methylmalonyl
CoA mutase [5].